Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

Surfactant Protein D Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:SP-D
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RD194059101 96 wells (1 kit)
PubMed Product Details
Technical Data


Sandwich ELISA, Biotin-labelled antibody


Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate, Bronchoalveolar lavage, Amniotic fluid

Sample Requirements

10 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1.56–100 ng/ml

Limit of Detection

0.01 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 2.2%

Inter-assay (Run-to-Run)

n = 5; CV = 3.1%

Spiking Recovery


Dilutation Linearity



  • bovine Yes
  • cat Non-detectable
  • dog Non-detectable
  • goat Non-detectable
  • hamster Non-detectable
  • horse Yes
  • mouse Non-detectable
  • pig Non-detectable
  • rabbit Non-detectable
  • rat Non-detectable
  • sheep Non-detectable
  • chicken Not tested
  • monkey Yes
  • human Yes


  • European Union: for in vitro diagnostic use
  • Rest of the world: for research use only!
  • The total assay time is less than 5 hours
  • The kit measures total surfactant protein D in serum, plasma (EDTA, citrate, heparin), bronchoalveolar lavage fluid and amniotic fluid
  • Assay format is 96 wells
  • Quality Controls are human serum based. No animal sera are used
  • Standard is recombinant protein based
  • Components of the kit are provided ready to use, concentrated or lyophilized

Research topic

Immune Response, Infection and Inflammation, Pulmonary diseases


Human Surfactant Protein D (SP-D) is a member of the collageneous subfamily of
glycoproteins and calcium-dependent lectins (collectins).
SP-D is a homotrimeric protein consisting of three 43kDa units that are bonded at their Ntermini.
Most preparations of SP-D contain predominantly dodecamers (four trimeric subunits),
but also higher multimers have been observed. Each unit consists of at least four discrete
structural domains: a short N-terminal domain; a relatively long collagenous domain, a short
amphipathic connecting peptide, and a C-terminal, C- type lectin carbohydrate recognition
domain (CRD).

SP-D is synthesized and secreted by two types of non-ciliated epithelial cells in the peripheral
airway, alveolar type II cells and Clara cells. It is also expressed by various epithelial cells in
the gastrointestinal and genitourinary tracts and placenta.
In the lungs, SP-D participates in the innate response to inhaled microorganisms and organic
antigens. SP-D acts by aggregating bacteria and viruses, leukocyte function and stimulating an
allergenic response. SP-D binds to the surface glycoconjugates of various microorganisms (eg,
influenza virus, HIV, HSV, RSV, Mycoplasma pneumoniae) and the oligosaccharides
associated with the surface of numerous organic antigens and enhances their phagocytosis.
Studies have shown that SP-D binds to T cells, thus inhibiting their proliferation. SP-D also
binds with inflammatory ligands via protein-protein and protein-carbohydrate interactions that
are effective in reducing specific inflammation. In addition, SP-D binds to apoptotic cells and
stimulates their phagocytosis by macrophages governed by mechanisms dependent and CD91

Given that SP-D together with SP-A affects the reactivity of immune cells, their presence in the
endometrium and placenta plays an important role in protection against bacteria and toxins
during pregnancy. Reduced levels of all components of pulmonary surfactant, including SP-D,
has been linked to premature birth.

Disturbance of pulmonary surfactant is in many cases the reason for collapse of the lungs and
is also associated with many pulmonary diseases. All types of chronic lung disease is
characterized by pathologically altered levels in lung tissue (fibrosis and emphysema). Studies
have shown that expression of SP-D is associated with many pulmonary diseases: cystic
fibrosis, acute interstitial pneumonia (ARDS), chronic obstructive pulmonary disease, asthma,
bronchopulmonary dysplasia, alveolar capillary dysplasia, alveolar proteinase and tuberculosis.
Clinical application and areas of investigation: Cystic fibrosis, Acute interstitial pneumonia (ARDS), Chronic obstructive pulmonary disease, Asthma, Bronchopulmonary dysplasia, Alveolar capillary dysplasia and alveolar proteinase, Immune response, infection and inflammation

References to Product


  • Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect. 2008 Jun;116 (6):799-805
  • Anderson JT, Zeng M, Li Q, Stapley R, Moore DR 2nd, Chenna B, Fineberg N, Zmijewski J, Eltoum IE, Siegal GP, Gaggar A, Barnes S, Velu SE, Thannickal VJ, Abraham E, Patel RP, Lancaster JR Jr, Chaplin DD, Dransfield MT, Deshane JS. Elevated levels of NO are localized to distal airways in asthma. Free Radic Biol Med. 2011 Jun 1;50 (11):1679-88
  • Aul R, Armstrong J, Duvoix A, Lomas D, Hayes B, Miller BE, Jagger C, Singh D. Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol. 2012 Dec;74 (6):1023-32
  • Ban WH, Kang HH, Kim IK, et al. Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease. Korean J Intern Med. 2018;33(4):745-752.
  • Barlo NP, van Moorsel CH, Ruven HJ, Zanen P, van den Bosch JM, Grutters JC. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung . 2009 Jul;26 (2):155-61
  • Bejvl I, Weseslindtner L, Strassl R, Jaksch P, Kundi M, Klepetko W, Puchhammer-Stockl E. Analysis of plasma surfactant protein D levels in lung transplant recipients. Transpl Infect Dis. 2013 Dec;15 (6):645-51
  • Bonlokke JH, Riddervold IS, Gronborg TK, Skogstrand K, Hougaard DM, Barregard L, Sigsgaard T. Systemic effects of wood smoke in a short-term experimental exposure study of atopic volunteers. J Occup Environ Med. 2014 Feb;56 (2):177-83
  • Bratcher PE, Gaggar A. Factors influencing the measurement of plasma/serum surfactant protein d levels by ELISA. PLoS One. 2014;9 (11):e111466
  • Bullone M, de Lagarde M, Vargas A, Lavoie JP. Serum Surfactant Protein D and Haptoglobin as Potential Biomarkers for Inflammatory Airway Disease in Horses. J Vet Intern Med. 2015 Nov-Dec;29 (6):1707-11
  • Choi S, Won YL, Kim D, Yi GY, Park JS, Kim EA. Subclinical interstitial lung damage in workers exposed to indium compounds. Ann Occup Environ Med. 2013;25(1):24. Published 2013 Oct 21. doi:10.1186/2052-4374-25-24
  • Chou CW, Chao HS, Lin FC, Tsai HC, Yuan WH, Chang SC. Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study. Medicine (Baltimore). 2015;94(16):e768.
  • Chou CW, Lin FC, Tsai HC, Chang SC. The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia. BMC Pulm Med. 2014;14:182. Published 2014 Nov 19. doi:10.1186/1471-2466-14-182
  • Daneshzadeh Tabrizi R, Bernard A, Thommen AM, De Winter F, Oppliger A, Hilfiker S, Tschopp A, Hotz P. Surfactant protein-D and exposure to bioaerosols in wastewater and garbage workers. Int Arch Occup Environ Health. 2010 Dec;83 (8):879-86
  • Delgado C, Krotzsch E, Jimenez-Alvarez LA, Ramirez-Martinez G, Marquez-Garcia JE, Cruz-Lagunas A, Moran J, Hernandez C, Sierra-Vargas P, Avila-Moreno F, Becerril C, Montano M, Banales-Mendez JL, Zuniga J, Buendia-Roldan I. Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection. Lung. 2015 Feb;193 (1):25-30
  • Duda I, Grzybowska K, Jedrzejowska-Szypulka H, Lewin-Kowalik J. The sitting position during neurosurgical procedures does not influence serum biomarkers of pulmonary parenchymal injury. BMC Surg. 2012;12:24
  • El-Deek SE, Makhlouf HA, Saleem TH, Mandour MA, Mohamed NA. Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease. Med Princ Pract. 2013;22 (5):469-74
  • Ellingsen DG, Ulvestad B, Andersson L, Barregard L. Pneumoproteins and inflammatory biomarkers in asphalt pavers. Biomarkers. 2010 Sep;15 (6):498-507
  • Engstrom G, Lindberg C, Gerhardsson de Verdier M, Nihlen U, Anderson M, Svartengren M, Forsman-Semb K. Blood biomarkers and measures of pulmonary function--a study from the Swedish twin registry. Respir Med. 2012 Sep;106 (9):1250-7
  • Erpenbeck VJ, Ziegert M, Cavalet-Blanco D, Martin C, Baelder R, Glaab T, Braun A, Steinhilber W, Luettig B, Uhlig S, Hoymann HG, Krug N, Hohlfeld JM. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin Exp Allergy. 2006 Jul;36 (7):930-40
  • Fernandez-Luna A, Gallardo L, Plaza-Carmona M, Garcia-Unanue J, Sanchez-Sanchez J, Felipe JL, Burillo P, Ara I. Respiratory function and changes in lung epithelium biomarkers after a short-training intervention in chlorinated vs. ozone indoor pools. PLoS One. 2013;8 (7):e68447
  • Fernandez-Real JM, Valdes S, Manco M, Chico B, Botas P, Campo A, Casamitjana R, Delgado E, Salvador J, Fruhbeck G, Mingrone G, Ricart W. Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care. 2010 Apr;33 (4):847-53
  • Font-Ribera L, Kogevinas M, Zock JP, Gomez FP, Barreiro E, Nieuwenhuijsen MJ, Fernandez P, Lourencetti C, Perez-Olabarria M, Bustamante M, Marcos R, Grimalt JO, Villanueva CM. Short-term changes in respiratory biomarkers after swimming in a chlorinated pool. Environ Health Perspect. 2010 Nov;118 (11):1538-44
  • Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, Bakke P, Gulsvik A, Lomas DA, Litonjua AA, Shapiro SD, Tal-Singer R, Silverman EK. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2011 Mar;44 (3):316-22
  • Gargiulo P, Banfi C, Ghilardi S, Magri D, Giovannardi M, Bonomi A, Salvioni E, Battaia E, Filardi PP, Tremoli E, Agostoni P. Surfactant-derived proteins as markers of alveolar membrane damage in heart failure. PLoS One. 2014;9 (12):e115030
  • Gaunsbaek MQ, Kjeldsen AD, Svane-Knudsen V, Henriksen ML, Hansen S. Surfactant proteins A, B, C and D in the human nasal airway: associated with mucosal glands and ciliated epithelium but absent in fluid-phase secretions and mucus. ORL J Otorhinolaryngol Relat S. 2014;76 (5):288-301
  • Gil HW, Hong JR, Park JH, Seo YS, Yang JO, Lee EY, Hong SY. Plasma surfactant D in patients following acute paraquat intoxication. Clin Toxicol (Phila). 2007 Jun-Aug;45 (5):463-7
  • Glas J, Beynon V, Bachstein B, Steckenbiller J, Manolis V, Euba A, Muller-Myhsok B, Folwaczny M. Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker. Tissue Antigens. 2008 Jul;72 (1):21-8
  • Guzel A, Karadag A, Okuyucu A, Alacam H, Kucuk Y. The evaluation of serum surfactant protein D (SP-D) levels as a biomarker of lung injury in tuberculosis and different lung diseases. Clin Lab. 2014;60 (7):1091-8
  • Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009 Apr;36 (4):773-80
  • Heldal KK, Barregard L, Larsson P, Ellingsen DG. Pneumoproteins in sewage workers exposed to sewage dust. Int Arch Occup Environ Health. 2013 Jan;86 (1):65-70
  • Hill J, Heslop C, Man SF, Frohlich J, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J. 2011 Aug;32 (15):1918-25
  • Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 Jul 15;178 (2):139-48
  • Holz O, Tan L, Schaumann F, Muller M, Scholl D, Hidi R, McLeod A, Krug N, Hohlfeld JM. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers. Pulm Pharmacol Ther. 2015 Dec;35:50-9
  • Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis Markers. 2012;32 (5):281-7
  • Karottki DG, Spilak M, Frederiksen M, Jovanovic Andersen Z, Madsen AM, Ketzel M, Massling A, Gunnarsen L, Moller P, Loft S. Indoor and outdoor exposure to ultrafine, fine and microbiologically derived particulate matter related to cardiovascular and respiratory effects in a panel of elderly urban citizens. Int J Environ Res Public Healt. 2015 Feb;12 (2):1667-86
  • Kor DJ, Carter RE, Park PK, Festic E, Banner-Goodspeed VM, Hinds R, Talmor D, Gajic O, Ware LB, Gong MN. Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial. JAMA. 2016 Jun 14;315 (22):2406-14
  • Kucejko W, Chyczewska E, Naumnik W, Ossolinska M. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis. Folia Histochem Cytobiol. 2009;47 (2):225-30
  • Kunisaki KM, Quick H, Baker JV. HIV antiretroviral therapy reduces circulating surfactant protein-D levels. HIV Med. 2011 Oct;12 (9):580-1
  • Liu HH, Chen CY, Chen GI, Lee LH, Chen HL. Relationship between indium exposure and oxidative damage in workers in indium tin oxide production plants. Int Arch Occup Environ Health. 2012 May;85 (4):447-53
  • Liu W, Ju CR, Chen RC, Liu ZG. Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease. Exp Ther Med. 2014;8(4):1313-1317.
  • Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J. 2009 Jul;34 (1):95-102
  • Miller J, Edwards LD, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Yates JC, Macnee W. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013 Sep;107 (9):1376-84
  • Mostafa S, Obaia M, Mahmoud Abd El Aziz G, Fathi M, Iaz N. Surfactant Protein D and C-Reactive Protein as serum biomarkers in Chronic Obstructive Pulmonary Disease. Bull. Egypt. Soc. Physiol. Sci. 2011;31 (1):179-193
  • Nickmilder M, Carbonnelle S, Bernard A. House cleaning with chlorine bleach and the risks of allergic and respiratory diseases in children. Pediatr Allergy Immunol. 2007 Feb;18 (1):27-35
  • Ozyurek BA, Ulasli SS, Bozbas SS, Bayraktar N, Akcay S. Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease. Multidiscip Respir Med. 2013;8 (1):36
  • Piperis M, Provatopoulou X, Sagkriotis A, Kalogera E, Ampatzoglou E, Zografos GC, Athanasiou E, Gounaris A. Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation. Anticancer Res. 2012 Nov;32 (11):4993-5002
  • Proudfoot A, Bayliffe A, O'Kane CM, et al. Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury. Thorax. 2018;73(8):723-730.
  • Richard EA, Pitel PH, Christmann U, Lekeux P, Fortier G, Pronost S. Serum concentration of surfactant protein D in horses with lower airway inflammation. Equine Vet J. 2011 Jun 23;
  • Sayiner A, Hague C, Ajlan A, Leipsic J, Wierenga L, Krowchuk NM, Ceylan N, Sayiner A, Sin DD, Coxson HO. Bronchiolitis in young female smokers. Respir Med. 2013 May;107 (5):732-8
  • Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J, Martin T, Goodlett DR. Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol. 2006 Jul;169 (1):86-95
  • Shakoori TA, Sin DD, Ghafoor F, Bashir S, Bokhari SN. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis Markers. 2009;27 (6):287-94
  • Shiels MS, Chaturvedi AK, Katki HA, Gochuico BR, Caporaso NE, Engels EA. Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Pr. 2011 Oct;20 (10):2262-72
  • Sims MW, Tal-Singer RM, Kierstein S, Musani AI, Beers MF, Panettieri RA, Haczku A. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res. 2008;9:13
  • Sin DD, Leung R, Gan WQ, Man SP. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med. 2007;7:13
  • Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 Jun 1;177 (11):1207-14
  • Sin DD, Man SF, McWilliams A, Lam S. Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer. Chest. 2008 Sep;134 (3):582-8
  • Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology. 2007;212 (4-5):381-416
  • Stapleton RD, Dixon AE, Parsons PE, Ware LB, Suratt BT. The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest. 2010 Sep;138 (3):568-77
  • Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, Akhtar SR, Ruzinski JT, Caldwell E, Curtis JR, Heyland DK, Watkins TR, Parsons PE, Martin JM, Wurfel MM, Hallstrand TS, Sims KA, Neff MJ. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med. 2011 Jul;39 (7):1655-62
  • Sun W, Kechris K, Jacobson S, ORCID:, Drummond MB, Hawkins GA, Yang J, Chen TH, Quibrera PM, Anderson W, Barr RG, Basta PV, ORCID:, Bleecker ER, Beaty T, Casaburi R, Castaldi P, Cho MH, Comellas A, Crapo JD, Criner G, Demeo D, Christenson SA, Couper DJ, Curtis JL, ORCID:, Doerschuk CM, Freeman CM, Gouskova NA, Han MK, Hanania NA, Hansel NN, Hersh CP, Hoffman EA, Kaner RJ, Kanner RE, Kleerup EC, Lutz S, Martinez FJ, Meyers DA, Peters SP, Regan EA, Rennard SI, Scholand MB, Silverman EK, Woodruff PG, O'Neal WK, Bowler RP. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet. 2016 Aug;12 (8):e1006011
  • Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008 Nov 24;205 (12):2703-10
  • Ulvestad B, Randem BG, Andersson L, Ellingsen DG, Barregard L. Clara cell protein as a biomarker for lung epithelial injury in asphalt workers. J Occup Environ Med. 2007 Oct;49 (10):1073-8
  • Um SJ, Lam S, Coxson H, Man SF, Sin DD. Budesonide/formoterol enhances the expression of pro Surfactant Protein-B in lungs of COPD patients. PLoS One. 2013;8 (12):e83881
  • Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier PA, Legrand D, Mathei C, Van Pottelbergh G, Degryse J. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr. 2010;10:39
  • Vizcaya D, Mirabelli MC, Orriols R, Anto JM, Barreiro E, Burgos F, Arjona L, Gomez F, Zock JP. Functional and biological characteristics of asthma in cleaning workers. Respir Med. 2013 May;107 (5):673-83
  • Wang SX, Liu P, Wei MT, Chen L, Guo Y, Wang RY, Tu ZG, Liang XC. Roles of serum clara cell protein 16 and surfactant protein-D in the early diagnosis and progression of silicosis. J Occup Environ Med. 2007 Aug;49 (8):834-9
  • Watkins TR, Rubenfeld GD, Martin TR, Nester TA, Caldwell E, Billgren J, Ruzinski J, Nathens AB. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med. 2008 May;36 (5):1493-9
  • Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res. 2011;12:29
  • Winkler C, Bahlmann O, Viereck J, Knudsen L, Wedekind D, Hoymann HG, Madsen J, Thum T, Hohlfeld JM, Ochs M. Impact of a Met(11)Thr single nucleotide polymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model. Exp Lung Res. 2014 Apr;40 (4):154-63
  • Wutzler S, Lehnert T, Laurer H, Lehnert M, Becker M, Henrich D, Vogl T, Marzi I. Circulating levels of Clara cell protein 16 but not surfactant protein D identify and quantify lung damage in patients with multiple injuries. J Trauma. 2011 Aug;71 (2):E31-6
  • Tekerek NU, Akyildiz BN, Ercal BD, Muhtaroglu S. New Biomarkers to Diagnose Ventilator Associated Pneumonia: Pentraxin 3 and Surfactant Protein D. Indian J Pediatr. 2018 Jun;85(6):426-432. doi: 10.1007/s12098-018-2607-2.
  • McNeil JB, Shaver CM, Kerchberger VE, Russell DW, Grove BS, Warren MA, Wickersham NE, Ware LB, McDonald WH, Bastarache JA. Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2018 Apr 15;197(8):1027-1035. doi: 10.1164/rccm.201707-1474OC.
  • Papaioannou AI, Konstantelou E, Papaporfyriou A, Bartziokas K, Spathis A, Bakakos P, Loukides S, Koulouris N, Papiris S, Kostikas K. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation. Lung. 2018 Apr;196(2):201-205. doi: 10.1007/s00408-018-0099-5.
References to Summary

References to Surfactant Protein D

  • Crouch EC. Surfactant protein-D and pulmonary host defense. Respir Res. 2000;1 (2):93-108
  • Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999 Dec;160 (6):1843-50
  • Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995 Dec;152 (6 Pt 1):1860-6
  • Inoue T, Matsuura E, Nagata A, Ogasawara Y, Hattori A, Kuroki Y, Fujimoto S, Akino T. Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D. J Immunol Methods. 1994 Aug 1;173 (2):157-64
  • Nagae H, Takahashi H, Kuroki Y, Honda Y, Nagata A, Ogasawara Y, Abe S, Akino T. Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta. 1997 Oct 31;266 (2):157-71
  • Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002 Feb 1;165 (3):378-81
  • Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000 Sep;162 (3 Pt 1):1109-14
  • Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med. 2000 Jul;162 (1):258-63
  • Ciftci F, Sen E, Arkan G, Acar D, Saryal S. The relation between serum surfactant protein-d level and chronic obstructive pulmonary disease severity.Biomedical Research (2018) Volume 29, Issue 7
Related Products Documents